curriculum vitae - Centro di Riferimento Oncologico di Aviano

KATY MASTORCI
VIA BORGO PIAZZA, 46
31010 FREGONA-OSIGO (TV)
ITALY
CURRICULUM VITAE
PERSONAL DATA
Surname: Mastorci
Name: Katy
Nationality: Italian
Date of Birth: 6 January 1983
Place of Birth: Fivizzano (MS), Italy
Marital Status: Single
EDUCATION AND TRAINING
Jan 2010-present: PhD student at University of Udine, Italy. Course topic:
Scienze e Tecnologie Cliniche.
March 2011-March 2013: Fellowship at “Centro di Riferimento
Oncologico, Dipartimento dei laboratori diagnostici e per le terapie
cellulari, Laboratorio di Bioimmunoterapie dei tumori umani (C.R.O. BIT)”
Aviano (PN), Italy. Project topic: Implementazione e ottimizzazione di
protocolli di immunoterapia adottiva e vaccino-terapia per neoplasie EBV
correlate.
Nov 2008-Dec 2010: A.I.R.C. Fellowship at “Centro di Riferimento
Oncologico, Dipartimeno di Oncologia Medica, Laboratorio di
Bioimmunoterapie dei tumori umani (C.R.O. BIT)” Aviano (PN), Italy.
Project topic: Mechanisms underlying apoptotic responses induced by
retinoic acid and Interferon-α in mantle cell lymphoma.
Dec 2007-Oct 2008: Scholarship at “Centro di Riferimento Oncologico,
Dipartimeno di Oncologia Medica, Laboratorio di Bioimmunoterapie dei
tumori umani (C.R.O. BIT)” Aviano (PN), Italy.
2005-2008: 2nd cycle degree course in Medical Biotechnologies at University
of Padova, Italy. (Two-years degree) - Grades obtained 106/110. Thesis
topic: Mechanisms underlying apoptotic responses induced by retinoic acid
and Interferon-α in mantle cell lymphoma.
Feb-Sep 2006: Combined study and practice period within ERASMUS
programme at “Universidad Autonoma de Barcelona (UAB)”.
Mar-Jun 2005: Scholarship at “Centro di Riferimento Oncologico,
Dipartimento Nucleo di Ricerca Clinica e Laboratoristica in Ematologia
(C.R.O. NRCLE)” Aviano (PN), Italy.
2002-2005: 1st cycle degree course in Medical Biotechnologies at University
of Padova, Italy. (Three-years degree) - Grades obtained 109/110. Thesis
topic: Role of “Proof-Reading” and “Error-Prone” DNA Polymerases in B
Cells Somatic Hypermutation in Chronic Linfatic Leukemia.
1997-2002: Science High School at “Istituto Marcantonio Flaminio di
Vittorio Veneto”. (Five-years degree) - Grades obtained 100/100.
LANGUAGES
Italian: Mother tongue.
Spanish: Fluent (oral), Very Good (written).
English: Very Good (oral and written).
- Attended advanced level course of “English language & Anglo Irish
literature programme” by “The faculty and board of management of ICON
INTERNATIONAL”, Dublin, September, 2000 - .
- Preliminary English Test (PET) by “University of Cambridge”, May, 2002 -.
Catalan: Fair understanding.
PUBLICATIONS
hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in
immortalized and transformed B cells: a basis for new therapies.
Giunco S, Dolcetti R, Keppel S, Celeghin A, Indraccolo S, Dal Col J, Mastorci K,
De Rossi A. Clin Cancer Res. 2013 Feb 26.
Alpha-interferon/retinoic acid combination inhibits growth and promotes
apoptosis in mantle cell lymphoma through Akt-dependent modulation of
critical targets.
Dal Col J, Mastorci K, Faè DA, Muraro E, Martorelli D, Inghirami G,
Dolcetti R. Cancer Res. 2012 Apr 1;72(7):1825-35.
A different immunologic profile characterizes patients with HER-2overexpressing and HER-2-negative locally advanced breast cancer:
implications for immune-based therapies.
Muraro E, Martorelli D, Turchet E, Miolo G, Scalone S, Comaro E, Talamini R,
Mastorci K, Lombardi D, Perin T, Carbone A, Veronesi A, Crivellari D,
Dolcetti R. Breast Cancer Res. 2011 Nov 23;13(6):R117.
ABSTRACTS
Giunco, Silvia; Dolcetti, Riccardo; Keppel, Sonia; Celeghin, Andrea; Indraccolo, Stefano;
Dal Col, Jessica; Mastorci, Katy; De Rossi, Anita.
The interplay between telomerase and Epstein Barr virus (EBV): silencing
of hTERT induces the EBV lytic cycle.
54th Annual Meeting of the Italian Cancer Society: “Mission impossible:
understanding cancer-host dialogues for personalized cancer medicine”,
Bologna, October 1-4, 2012.
Mastorci K., Dal Col J., Comaro E., Martorelli D., Faè D.A., Muraro E., Pasini
E., and Dolcetti R.
Akt inhibition promotes both apoptosis and autophagy in different types of
lymphoma.
54th Annual Meeting of the Italian Cancer Society: “Mission impossible:
understanding cancer-host dialogues for personalized cancer medicine”,
Bologna, October 1-4, 2012.
D.A. Faé, D. Martorelli, E. Muraro, K. Mastorci, E. Vaccher, L. Barzan, G.
Franchin, E. Comaro, A. Carbone, R. Dolcetti.
Generation Of EBV-Specific CTL Lines Enriched In BARF1 Specificities
For Improved Adoptive Immunotherapy Of Nasopharyngeal Carcinoma.
22nd Biennal Congress of the European Association for Cancer Treatment:
“From Basic Research to Personalized Cancer Treatment”, Barcelona –
Spain – July 7-10, 2012.
Mastorci K., Dal Col J., Faè D.A., Inghirami G., Ponzoni M., Doglioni C., and
Dolcetti R.
Phospholipid scramblase 1 sensitizes mantle cell lymphoma to apoptosis
induced
by
several
drugs.
22nd Biennal Congress of the European Association for Cancer Treatment:
“From Basic Research to Personalized Cancer Treatment”, Barcelona –
Spain – July 7-10, 2012.
Mastorci K., Dal Col J., Faè D.A., Inghirami G., Ponzoni M., Doglioni C., and
Dolcetti R.
9-cis-retinoic acid/interferon-α combination sensitizes mantle cell
lymphoma to Doxorubicin and Bortezomib-induced apoptosis through
phospholipid scramblase 1 up-regulation.
53st Annual Meeting of the Italian Cancer Society: “Back to the Future:
Translating Cancer Research from Bedside to Bench and Back”, Turin,
October 19-22, 2011.
Mastorci K., Dal Col J., Bergamin S., Pasini E., Muraro E., Martorelli D., Rizzo
S., Ponzoni M., Doglioni C., and Dolcetti R.
Phospholipid scramblase 1 mediates 9-cis-retinoic acid/interferon-αdependent apoptosis in mantle cell lymphoma.
51st Annual Meeting of the Italian Cancer Society: “Cancer research in the
technological post-industrial era”, Sesto San Giovanni – Milan, November
23-26, 2009.
Jessica Dal Col, Katy Mastorci, Stefano Bergamin, Alessandro Pavan, Paola
Zancai, Elena Muraro, Silvana Rizzo and Riccardo Dolcetti.
alpha-Interferon and retinoic acid combination induces strong
antiproliferative and pro-apoptotic effects in mantle cell lymphoma.
51st Annual Meeting of the Italian Cancer Society: “Cancer research in the
technological post-industrial era”, Sesto San Giovanni – Milano, November
23-26, 2009.
Jessica Dal Col, Katy Mastorci, Stefano Bergamin, Alessandro Pavan, Paola
Zancai, Elena Muraro, Silvana Rizzo and Riccardo Dolcetti.
alpha-Interferon and retinoic acid combination induces strong
antiproliferative and pro-apoptotic effects in mantle cell lymphoma.
17th ECDO Euroconference: “Destruction, Degradation and Death Cell
Death Control in Cancer and Neurodegeneration”, Institut Pasteur, Paris,
France, September 23-26, 2009.
CERTIFICATES OF ATTENDANCE
54th Annual Meeting of the Italian Cancer Society: “Mission impossible:
understanding cancer-host dialogues for personalized cancer medicine”,
Bologna, October 1-4, 2012.
22nd Biennal Congress of the European Association for Cancer Treatment:
“From Basic Research to Personalized Cancer Treatment”, Barcelona –
Spain – July 7-10, 2012.
“Young Researchers at CRO Aviano” event, C.R.O. Aviano, April 12-13,
2012 (where I was winner of the award for the best poster. Poster topic:
“Erlotinib as targeted therapy with positive off-target effects in pancreatic
cancer: does the EGFR inhibitory action mask an immune-stimulating
effect?”).
“Leggere e scrivere in inglese scientifico: training di secondo livello” course,
C.R.O. Aviano, August 20, 2011-February 20, 2012.
“Analisi Biostatistica a supporto dei progetti di ricerca” course, C.R.O.
Aviano, February 8-10, 2012.
53st Annual Meeting of the Italian Cancer Society: “Back to the Future:
Translating Cancer Research from Bedside to Bench and Back”, Turin,
October 19-22, 2011.
“Corso di Reference Work” course, C.R.O. Aviano, September 7, 2011.
“Young investigators event: la due-giorni dei giovani ricercatori dell’IRCCS
CRO” Congress, C.R.O. Aviano, May 3-4, 2011.
“Young investigators event: la due-giorni dei giovani ricercatori dell’IRCCS
CRO” Congress, C.R.O. Aviano, March 10-11, 2010 (where I was speaker).
51st Annual Meeting of the Italian Cancer Society: “Cancer research in the
technological post-industrial era”, Sesto San Giovanni – Milano, November
23-26, 2009.
“Informazione scientifica in un IRCCS oncologico: formazione all’uso
delle risorse informative rese disponibili dalla Biblioteca del CRO,
BiblioSan” course, C.R.O. Aviano, September 29, 2009.
MARGINAL WORK EXPERIENCE (NOT RELATED TO MY EDUCATION)
2007 Seasonal bar tender in a pub.